|
Volumn 31, Issue 3-6, 2001, Pages 141-147
|
Alfimeprase: Pharmacology of a novel fibrinolytic metalloproteinase for thrombolysis
|
Author keywords
Alfimeprase; Fibrinolysis; Fibrolase; Metalloprotease; Thrombolysis; Thrombosis
|
Indexed keywords
ALFIMEPRASE;
ALPHA 2 MACROGLOBULIN;
FIBRINOGEN;
FIBRINOLYTIC AGENT;
FIBROLASE;
METALLOPROTEINASE;
PLASMINOGEN ACTIVATOR;
PROTEINASE INHIBITOR;
SNAKE VENOM;
UNCLASSIFIED DRUG;
UROKINASE;
ANIMAL EXPERIMENT;
ARTICLE;
BLEEDING;
BLOOD CLOT LYSIS;
CONTROLLED STUDY;
DRUG ACTIVITY;
ENZYME ACTIVITY;
ENZYME INHIBITION;
IN VIVO STUDY;
NONHUMAN;
PRIORITY JOURNAL;
PROTEIN DEGRADATION;
PROTEIN PROTEIN INTERACTION;
RAT;
SNAKE;
ANIMAL;
DRUG ANTAGONISM;
FIBRINOLYTIC THERAPY;
HUMAN;
METABOLISM;
METHODOLOGY;
REVIEW;
ALPHA-MACROGLOBULINS;
ANIMALS;
FIBRINOLYTIC AGENTS;
HUMANS;
METALLOENDOPEPTIDASES;
THROMBOLYTIC THERAPY;
|
EID: 0035742236
PISSN: 03010147
EISSN: None
Source Type: Journal
DOI: 10.1159/000048057 Document Type: Article |
Times cited : (61)
|
References (9)
|